跳至主要内容
临床试验/EUCTR2020-001638-37-HU
EUCTR2020-001638-37-HU进行中(未招募)1 期

Comparison of the preventive painkiller effect of etoricoxib and celecoxib after M3M surgery: A randomized, double-masked clinical trial

Semmelweis Egyetem Fogorvostudományi Kar Arc- Állcsont- Szájsebészeti és Fogászati Klinika, Budapest0 个研究点目标入组 75 人开始时间: 2020年6月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • female and male patients aged between 18 and 30, without any current medical conditions or existing in the medical history.
  • class I and II, A and B positioned (Pell & Gregory) wisdom teeth will be removed (with the exception of Class II B- due to the more invasive surgery a longer healing period is suspected)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 75
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients will be excluded if the following conditions exist:
  • - patients under medication (we would like to avoid the interactions)
  • - patients who have taken any type of a painkiller during the week prior to the surgery
  • - smokers (longer healing period is suspected)
  • - pregnancy
  • - patients in breast feeding period
  • - patients with allergy for the examined medicaments

研究者

发起方
Semmelweis Egyetem Fogorvostudományi Kar Arc- Állcsont- Szájsebészeti és Fogászati Klinika, Budapest

相似试验